That is why Group’s commitment is even more crucial: guaranteeing the integrity of vaccines and tracing each dose through visual inspection and serialization processes of the single vial, to bring safety and transparency to the vaccine distribution chain and guarantee fairness and correctness. The Italian multinational has in fact designed and already installed on the lines of several pharmaceutical companies solutions for visual inspection and serialization of the vials, also in integrated mode: the first allows to eliminate human error in quality control, guaranteeing extremely high volumes of inspected vials (up to 400 pieces/min), the second allows traceability at a global level, reducing interruptions in the supply chain and making the supply chain transparent, a fundamental aspect in this phase of the vaccine campaign.
In particular, the latest solution of Antares Vision, belonging to the panel of patented applications for visual inspection, is equipped with innovative technologies to allow accurate visual inspection for liquids and/or lyophilized products, a Container Closure Integrity Testing and, in integrated mode, the unique serialization of the single dose (in-line printing and control of data matrix code with visible or UV-visible ink, to share information with health authorities and throughout the supply chain).
The pandemic has accelerated the use and experience of new technologies - commented Emidio Zorzella, President and CEO of Antares Vision - and it is very important that people's safety is addressed. Now more than ever, therefore, technology must help to reduce the emergency situation and our contributions aid in vaccine integrity and distribution transparency. With this in mind, we are exploring with IBM and the Linux Foundation, how blockchain technology may further secure along the vaccine supply chain."